NextCure Inc.

NASDAQ: NXTC · Real-Time Price · USD
5.17
0.02 (0.43%)
At close: Aug 15, 2025, 3:47 PM
5.00
-3.38%
After-hours: Aug 15, 2025, 06:39 PM EDT

NextCure Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.28M 3.28M 3.28M 6.28M 6.28M 6.28M 6.28M n/a n/a n/a n/a n/a n/a n/a n/a 0.00 0.00 0.00
Cost of Revenue
1.99M 2.06M 2.34M 3.17M 3.41M 3.8M 3.97M 3.14M 3.22M 2.13M 3.12M 5.22M 6.3M 8.19M 7.2M 17.2M 27.84M 37.08M
Gross Profit
-346K -414K -700K 3.12M 2.87M 2.49M 2.32M -3.14M -3.22M -2.13M -3.12M -5.22M -6.3M -8.19M -7.2M -17.2M -27.84M -37.08M
Operating Income
-63.86M -53.07M -57.21M -60.54M -63.66M -66.33M -67.64M -69.62M -73.24M -72.21M -75.91M -75.21M -74.48M -74.3M -70.77M -69.93M -68.82M -66.67M
Interest Income
n/a n/a n/a n/a 1.32K 2.62K 2.62K 2.62K 1.3K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-60.93M -49.52M -55.65M -58.52M -61.28M -63.73M -62.72M -65.56M -70.17M -70.23M -74.73M -74.37M -73.39M -73.46M -69.39M -67.91M -66.35M -62.87M
Net Income
-60.93M -49.52M -55.65M -58.52M -61.28M -63.73M -61.75M -64.58M -68.86M -68.72M -74.03M -73.67M -73.02M -73.29M -69.39M -67.91M -66.35M -62.87M
Selling & General & Admin
14.21M 14.38M 15.02M 14.6M 15.49M 17.82M 18.88M 20.69M 21.8M 21.39M 21.71M 21.57M 20.77M 21.47M 20.57M 19.9M 19.64M 18.31M
Research & Development
49.66M 37.99M 41.49M 44.41M 46.65M 47.68M 47.93M 48.93M 51.44M 50.82M 54.2M 53.64M 53.71M 52.83M 50.19M 50.03M 49.18M 48.36M
Other Expenses
n/a n/a 2.54M 3.37M 3.37M 4.67M 3.1M 2.27M 2.6M 1.3M 497K 629K 879K 844K 1.38M 2.02M 2.47M 3.8M
Operating Expenses
63.86M 52.37M 59.05M 62.38M 65.5M 68.87M 67.64M 69.62M 73.24M 72.21M 75.91M 75.21M 74.48M 74.3M 70.77M 69.93M 68.82M 66.67M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a -701K -701K -1.52M -1.52M -824K -824K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
63.86M 53.07M 57.21M 60.54M 63.66M 66.33M 67.64M 69.62M 73.24M 72.21M 75.91M 75.21M 74.48M 74.3M 70.77M 69.93M 68.82M 66.67M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -975K -975K -1.3M -1.51M -704K -704K -376K -169K n/a n/a n/a n/a
Shares Outstanding (Basic)
2.37M 2.33M 2.33M 2.33M 2.33M 2.33M 2.33M 2.32M 2.32M 2.31M 2.31M 2.31M 2.31M 2.31M 2.3M 2.3M 2.3M 2.3M
Shares Outstanding (Diluted)
2.37M 2.33M 2.33M 2.33M 2.33M 2.33M 2.33M 2.32M 2.32M 2.31M 2.31M 2.31M 2.31M 2.31M 2.3M 2.3M 2.3M 2.3M
EPS (Basic)
-25.91 -21.23 -23.89 -25.14 -26.35 -27.44 -27.04 -28.29 -30.31 -30.36 -32.33 -32.2 -31.82 -31.88 -30.15 -29.53 -28.87 -27.37
EPS (Diluted)
-25.91 -21.23 -23.89 -25.14 -26.35 -27.44 -27.04 -28.29 -30.31 -30.36 -32.33 -32.2 -31.82 -31.88 -30.15 -29.53 -28.87 -27.37
EBITDA
-61.84M -50.34M -54.34M -57.53M -60.4M -62.81M -63.95M -65.75M -69.3M -68.18M -71.78M -69.86M -68.41M -68.98M -65.39M -65.81M -65.55M -62.9M
EBIT
-63.38M -53.07M -57.21M -60.54M -63.66M -66.33M -67.64M -69.62M -73.24M -72.21M -75.91M -75.21M -74.48M -74.3M -70.77M -69.93M -68.82M -66.67M
Depreciation & Amortization
2.03M 2.73M 2.87M 3.02M 3.26M 3.65M 3.97M 4.15M 4.22M 4.18M 5.16M 6.26M 7.33M 8.19M 7.2M 6.08M 4.87M 3.77M